Adding Streptomycin to an Intensified Regimen for Tuberculous Meningitis Improves Survival in HIV-Infected Patients.
Gerardo Alvarez-Uria, Raghavakalyan Pakam, Manoranjan Midde...
https://pubmed.ncbi.nlm.nih.gov/26347376/Actively Recruiting
Led by Rural Development Trust Hospital · Updated on 2023-03-29
30000
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are conducting a long-term prospective study called the Vicente Ferrer HIV Cohort Study VFHCS to understand HIV and related health issues in a rural area of India with high HIV prevalence. The study aims to describe how HIV spreads, its social and medical impact, and the effectiveness of health programs in real-world conditions. It focuses on various aspects including opportunistic infections like tuberculosis, life expectancy, treatment effects, and non-communicable diseases in people living with HIV. The VFHCS collects routine clinical data from HIV-infected patients attending Bathalapalli Rural Development Trust Hospital since September 2009. Data include information on HIV transmission, risk factors, treatments such as antiretroviral therapy, laboratory tests like CD4 counts, and medical diagnoses. The study continues to gather data to evaluate trends, treatment toxicity, and program effectiveness over time in this rural setting. Participants are followed over many years, with researchers tracking mortality and health outcomes from the time of HIV diagnosis, using time-to-event methods for up to 30 years. The study collects social, medical, and laboratory data regularly to monitor disease progression, treatment response, and retention in care. This long-term monitoring helps to understand factors influencing survival and health among rural Indian patients living with HIV.
CONDITIONS
Vicente Ferrer HIV Cohort Study
G
Gerardo Alvarez-Uria
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rural Development Trust Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 years from HIV diagnosis
Participants who have tested positive for HIV are observed with routine clinical data collected prospectively, including medical treatments, laboratory tests, and standardized diagnoses.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Gerardo Alvarez-Uria, Raghavakalyan Pakam, Manoranjan Midde...
https://pubmed.ncbi.nlm.nih.gov/26347376/Gerardo Alvarez-Uria, Raghavakalyan Pakam, Manoranjan Midde...
https://pubmed.ncbi.nlm.nih.gov/25499123/Gerardo Alvarez-Uria, Manoranjan Midde, Raghavakalyan Pakam...
https://pubmed.ncbi.nlm.nih.gov/24163804/Gerardo Alvarez-Uria, Praveen Kumar Naik, Manoranjan Midde...
https://pubmed.ncbi.nlm.nih.gov/24348184/Gerardo Alvarez-Uria, Manoranjan Midde, Raghavakalyan Pakam...
https://pubmed.ncbi.nlm.nih.gov/24069604/Gerardo Alvarez-Uria, Manoranjan Midde, Raghavakalyan Pakam...
https://pubmed.ncbi.nlm.nih.gov/22701801/Gerardo Alvarez-Uria, Raghavakalyan Pakam, Manoranjan Midde...
https://pubmed.ncbi.nlm.nih.gov/24288689/Gerardo Alvarez-Uria, Manoranjan Midde, Praveen K Naik
https://pubmed.ncbi.nlm.nih.gov/27231666/Gerardo Alvarez-Uria, Praveen Kumar Naik, Rhagavakalyan Pakam...
https://pubmed.ncbi.nlm.nih.gov/22487689/Andrew D Revell, Gerardo Alvarez-Uria, Dechao Wang...
https://pubmed.ncbi.nlm.nih.gov/24175292/Rural Development Trust Hospital
Lead Sponsor